Paul Saladino· MD
so you could combine the parasitology of doctor's data with longevity potentially right
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so you could combine the parasitology of doctor's data with longevity potentially right
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so you might combine longevity with either gi effects or gi map yeah potentially or or even um you know i i don't love culture based right gmap is mostly culture based right as uh gi map is qpcr now it went to qpcr oh no the gm that's qpcr but the gi effects doctor's data are culture-based
so probably one gevity plus gi map is the best we've got right now yeah i mean that's unfortunate that that's the case because it does end up being very expensive when you're you know combining all of those to get the different aspects right right